FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease
The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent ( Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh ( femoropopliteal artery) when narrowed or blocked as a result of peripheral artery disease (PAD).
